- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 241/00 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
Patent holdings for IPC class C07D 241/00
Total number of patents in this class: 84
10-year publication summary
|
5
|
2
|
2
|
4
|
0
|
3
|
1
|
2
|
2
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Merck Sharp & Dohme Corp. | 2219 |
4 |
| Allergan, Inc. | 2445 |
3 |
| Merck Sharp & Dohme LLC | 3744 |
3 |
| Hoffmann-La Roche Inc. | 3255 |
2 |
| BASF SE | 20387 |
2 |
| Boehringer Ingelheim International GmbH | 4756 |
2 |
| Janssen Pharmaceutica N.V. | 3624 |
2 |
| Amgen Inc. | 3897 |
2 |
| JNC Corporation | 1532 |
2 |
| Pharmacosmos A/S | 69 |
2 |
| Pharmacosmos Holding A/S | 185 |
2 |
| Novartis AG | 11289 |
1 |
| F. Hoffmann-La Roche AG | 7939 |
1 |
| LG Chem, Ltd. | 17632 |
1 |
| AstraZeneca AB | 2961 |
1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 96 |
1 |
| Syngenta Participations AG | 3033 |
1 |
| Centre National de La Recherche Scientifique | 10068 |
1 |
| Bayer Cropscience AG | 2142 |
1 |
| Evonik Degussa GmbH | 1557 |
1 |
| Other owners | 49 |